13 Publications
2009
Differences in the temporal expression of regulatory growth factors during choroidal neovascular development.
Hu, Wenzheng⋅Criswell, Mark H⋅Fong, Shao-Ling⋅Temm, Constance J⋅Rajashekhar, Gangaraju⋅Cornell, Tammy L and Clauss, Matthias A
Experimental eye research, vol. 88, (no. 1), pp. 79-91, 2009/Jan. | Journal Article
2008
Comparing Pegaptanib and Triamcinolone Efficacy in the Rat Choroidal Neovascularization Model
Criswell, Mark H⋅Hu, Wen-Zheng⋅Steffens, Timothy J⋅Li, Ruihong and Margaron, Philippe
Archives of Ophthalmology, vol. 126, (no. 7), Jul 2008. | Journal Article
2005
Anastomotic vessels remain viable after photodynamic therapy in primate models of choroidal neovascularization.
Criswell, Mark H⋅Ciulla, Thomas A⋅Lowseth, Lisa A⋅Small, Ward⋅Danis, Ronald and Carson, Dennis L
Investigative ophthalmology & visual science. , vol. 46, (no. 6), pp. 2168-74, 2005/Jun. | Journal Article
 
Future pharmacological treatment options for nonexudative and exudative age-related macular degeneration.
Comer, Grant M⋅Ciulla, Thomas A⋅Heier, Jeffery S and Criswell, Mark H
Expert opinion on emerging drugs. , vol. 10, (no. 1), pp. 119-35, 2005/Feb. | Journal Article
 
Oral administration of lumiracoxib reduces choroidal neovascular membrane development in the rat laser-trauma model.
Hu, Wenzheng⋅Criswell, Mark H⋅Ottlecz, Anna⋅Cornell, Tammy L⋅Danis, Ronald⋅Lambrou, George N and Ciulla, Thomas A
Retina (Philadelphia, Pa.), vol. 25, (no. 8), pp. 1054-64, 2005/Dec. | Journal Article
2004
Corticosteroids in posterior segment disease: an update on new delivery systems and new indications.
Ciulla, Thomas A⋅Walker, Jonathan D⋅Fong, Donald S and Criswell, Mark H
Current opinion in ophthalmology, vol. 15, (no. 3), pp. 211-20, 2004/Jun. | Journal Article
 
Current and future treatment options for nonexudative and exudative age-related macular degeneration.
Comer, Grant M⋅Ciulla, Thomas A⋅Criswell, Mark H and Tolentino, Michael
Drugs & aging, vol. 21, (no. 15), pp. 967-92, 2004. | Journal Article
 
Evaluation of photopoint photosensitizer mv6401, indium chloride methyl pyropheophorbide, as a photodynamic therapy agent in primate choriocapillaris and laser-induced choroidal neovascularization.
Ciulla, Thomas A⋅Criswell, Mark H⋅Danis, Ronald⋅Snyder, Wendy J and Small, Ward
Retina (Philadelphia, Pa.), vol. 24, (no. 4), pp. 521-9, 2004/Aug. | Journal Article
 
The squirrel monkey: characterization of a new-world primate model of experimental choroidal neovascularization and comparison with the macaque.
Criswell, Mark H⋅Ciulla, Thomas A⋅Hill, Tiffany E⋅Small, Ward⋅Danis, Ronald⋅Snyder, Wendy J⋅Lowseth, Lisa A and Carson, Dennis L
Investigative ophthalmology & visual science. , vol. 45, (no. 2), pp. 625-34, 2004/Feb. | Journal Article
2003
Pharmacologic therapy for diabetic retinopathy
Speicher, M. A⋅Danis, Ronald⋅Criswell, Mark H and Pratt, L.
Expert Opinion on Emerging Drugs, vol. 8, (no. 1), pp. 239-250, 2003. | Journal Article
 
Squalamine lactate reduces choroidal neovascularization in a laser-injury model in the rat.
Ciulla, Thomas A⋅Criswell, Mark H⋅Danis, Ronald⋅Williams, Jon I⋅McLane, Michael P and Holroyd, Kenneth J
Retina (Philadelphia, Pa.), vol. 23, (no. 6), pp. 808-14, 2003/Dec. | Journal Article
2002
An update on photodynamic therapy in age-related macular degeneration.
Rechtman, Ehud⋅Ciulla, Thomas A⋅Criswell, Mark H⋅Pollack, Ayala and Harris, Alon
Expert opinion on pharmacotherapy, vol. 3, (no. 7), pp. 931-8, 2002/Jul. | Journal Article
2001
Intravitreal triamcinolone acetonide inhibits choroidal neovascularization in a laser-treated rat model
Ciulla, Thomas A⋅Criswell, Mark H⋅Danis, Ronald and Hill, Tiffany E
Archives of Ophthalmology, vol. 119, (no. 3), pp. 399-404, Mar 2001. | Journal Article